This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2 testing in various types of advanced solid tumors. Different testing methods may be used to detect HER2 overexpression, HER2 amplification, and HER2 mutations.
Activity Agenda
-
Introductions
-
Testing methods
-
Clinical implications
-
Practical considerations
-
Wrap up
Target Audience
This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team.
Learning Objectives
Upon completion of this activity, you will be able to:
-
Identify when HER2 testing may be indicated in patients with advanced solid tumors
-
Describe how the use of certain HER2-directed therapy may impact clinical outcomes in patients with advanced solid tumors based on HER testing results
-
Outline how HER2 testing may be performed in different types of advanced solid tumors
Faculty
Marilyn M. Bui, MD, PhD, FCAP Professor and Senior Member in the Department of Pathology at Moffitt Cancer Center
Swikrity U Baskota,MD, FCAP
Assistant Professor in the Department of Pathology and Laboratory Medicine
University of California Davis Health System
Laura J. Tafe, MD
Associate Professor of Pathology and Laboratory Medicine at Dartmouth-Hitchcock Medical Center
Emmanuel Garcia, MD
Resident Pathologist at Northwestern University
Meredith Herman, DO
Resident Pathologist at the University of Michigan
Faculty Disclosures
All relevant financial relationships for Marilyn M. Bui and Swikrity U Baskota have been mitigated. Laura Tafe, Emmanual Garcia, and Meredith Herman have no financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must attend the live activity. CME certificates will be provided on-line.
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.